These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6785124)

  • 1. Virologic control of monkeys used for the production of poliomyelitis virus vaccine.
    Osterhaus AD; van Steenis G
    Dev Biol Stand; 1981; 47():157-61. PubMed ID: 6785124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of captive-bred monkeys for vaccine production.
    van Steenis G; van Wezel AL; de Groot IG; Kruijt BC
    Dev Biol Stand; 1980; 45():99-105. PubMed ID: 6772513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The production of inactivated poliovaccine on serially cultivated kidney cells from captive-bred monkeys.
    van Wezel AL; van der Velden-de Groot CA; van Herwaarden JA
    Dev Biol Stand; 1980; 46():151-8. PubMed ID: 6244995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breeding of Macaca fascicularis for poliovaccine production.
    Boot R; Kruijt BC; van Steenis G; van Wezel AL
    Dev Biol Stand; 1981; 47():15-8. PubMed ID: 7227650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Present state and developments in the production of inactivated poliomyelitis vaccine.
    van Wezel AL
    Dev Biol Stand; 1981; 47():7-13. PubMed ID: 6262162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on safety tests of inactivated poliomyelitis vaccines. V. Pathomorphological changes in the CNS of rhesus monkeys (Macaca rhesus) and long-tailed monkeys (Cercopithecus aethiops) following intracerebral and intralumbar inoculation with inactivated poliovirus types I, II, and 3].
    Unterharnscheidt F; Günther O; Hövel H; Burde K; Heber L
    Zentralbl Bakteriol Orig; 1966 Jun; 200(2):150-66. PubMed ID: 4296871
    [No Abstract]   [Full Text] [Related]  

  • 7. Scrub Typhus antibody in cynomolgus monkeys (Macaca fascicularis) in Malaysia.
    Heisey GB; Gan E; Shirai A; Groves MG
    Lab Anim Sci; 1981 Jun; 31(3):289-91. PubMed ID: 6790836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International comparison of species of monkey used for the neurovirulence test for oral poliomyelitis vaccine.
    Boulger LR; Arya SC; Ahourai P; Marsden SA
    J Biol Stand; 1978 Jul; 6(3):233-42. PubMed ID: 102647
    [No Abstract]   [Full Text] [Related]  

  • 9. Chimeric dengue type 2/type 1 viruses induce immune responses in cynomolgus monkeys.
    Butrapet S; Rabablert J; Angsubhakorn S; Wiriyarat W; Huang C; Kinney R; Punyim S; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):589-99. PubMed ID: 12693596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue-3 (16562) PGMK 33 vaccine: neurovirulence, viremia and immune responses in Macaca fascicularis.
    Angsubhakorn S; Yoksan S; Pradermwong A; Nitatpattana N; Sahaphong S; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 1994 Sep; 25(3):554-9. PubMed ID: 7777925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antibody reaction with cercopithecine herpesvirus 1 antigen in Macaca cyclopis, Macaca fascicularis, and Papio anubis in Taiwan.
    Lee F; Lin YJ; Deng MC; Lee TY; Huang CC
    J Med Primatol; 2007 Dec; 36(6):343-7. PubMed ID: 17976038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring vaccines for human oncogenicity.
    Miller RW
    Natl Cancer Inst Monogr; 1968 Dec; 29():453-5. PubMed ID: 4305436
    [No Abstract]   [Full Text] [Related]  

  • 13. A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine.
    Wood DJ; Heath AB; Kersten GF; Hazendonk T; Lantinga M; Beuvery EC
    Biologicals; 1997 Mar; 25(1):59-64. PubMed ID: 9167009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of rickettsial antibody and cell-mediated reaction in cynomolgus monkeys (Macaca fascicularis).
    Kishimoto RA; Gonder JC
    Lab Anim Sci; 1980 Dec; 30(6):1016-7. PubMed ID: 7007722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurovirulence.
    Wood D
    Dev Biol Stand; 1999; 101():127-9. PubMed ID: 10566785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of experimental Rickettsia tsutsugamushi infections in silvered leaf (Presbytis cristatus) and cynomolgus (Macaca fascicularis) monkeys.
    Shirai A; Montrey RD; Werner RM; Arimbalam S; Huxsoll DL
    Jpn J Med Sci Biol; 1979 Dec; 32(6):345-51. PubMed ID: 120902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian cells and their contaminants.
    Minor PD
    Dev Biol Stand; 1996; 88():25-9. PubMed ID: 9119147
    [No Abstract]   [Full Text] [Related]  

  • 18. Viral vaccines: various cell substrates and long-term prospective studies.
    Kirschstein RL; Petricciani JC
    Adv Exp Med Biol; 1972; 31(0):197-206. PubMed ID: 4212515
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on new attenuated strains of type III live poliomyelitis vaccine. I. Development of a new type III attenuated poliovirus.
    Chin Med J (Engl); 1980 Sep; 93(9):583-90. PubMed ID: 6253236
    [No Abstract]   [Full Text] [Related]  

  • 20. Innate anti-viral immunity is associated with the protection elicited by the simian immunodeficiency virus (SIV) live attenuated virus vaccine in cynomolgus monkeys.
    Goletti D; Macchia I; Leone P; Pace M; Sernicola L; Pavone-Cossut MR; Maggiorella MT; Cafaro A; Ensoli B; Titti F
    Med Sci Monit; 2006 Oct; 12(10):BR330-40. PubMed ID: 17006396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.